Publications

Detailed Information

Drug Persistency with Cholinesterase Inhibitors for Elderly Patients with Alzheimer`s Disease in Korea

DC Field Value Language
dc.contributor.authorAhn, So-Hyeon-
dc.contributor.authorKim, Ye-Jee-
dc.contributor.authorJung, Sun-Young-
dc.contributor.authorChoi, Nam-Kyong-
dc.contributor.authorPark, Byung-Joo-
dc.contributor.authorShin, Ju-Young-
dc.date.accessioned2012-06-27T01:31:50Z-
dc.date.available2012-06-27T01:31:50Z-
dc.date.issued2009-08-
dc.identifier.citationPHARMACOEPIDEMIOLOGY AND DRUG SAFETY; Vol.18 ; S236-S237ko_KR
dc.identifier.issn1053-8569-
dc.identifier.urihttps://hdl.handle.net/10371/77515-
dc.description.abstractBackground: Persistence to Cholinesterase-Inhibitors
(ChEIs) treatment in Alzheimers disease (AD) patients sustains
cognitive, functional, and behavioral benefits and
delays the progress of the disease.
ko_KR
dc.language.isoenko_KR
dc.publisherJOHN WILEY & SONS LTDko_KR
dc.titleDrug Persistency with Cholinesterase Inhibitors for Elderly Patients with Alzheimer`s Disease in Koreako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor안소현-
dc.contributor.AlternativeAuthor김예지-
dc.contributor.AlternativeAuthor정선영-
dc.contributor.AlternativeAuthor최남경-
dc.contributor.AlternativeAuthor신주영-
dc.contributor.AlternativeAuthor박병주-
dc.citation.journaltitlePHARMACOEPIDEMIOLOGY AND DRUG SAFETY-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share